This commentary provides an overview of the evolving field of radiomics, which aims to noninvasively augment clinical prognostic nomograms, correlate imaging phenotypes, and support clinical decision‐making.
Keywords: Non‐small cell lung cancer; Prognostic; Radiomics; Texture metrics.